C&EN White Paper
Powering drug development with advanced AI retrosynthetic analysis tools
Brought to you by Lonza Small Molecules

As small molecule APIs become increasingly complex, longer synthetic pathways present new challenges for process chemists. Drug developers are turning to evolving tools to find reliable and efficient synthesis routes to produce small molecule APIs. This white paper outlines the advanced retrosynthetic analysis services offered by Lonza’s Small Molecules division and how these tools empower better, more efficient development of innovative small molecule drugs.

Key Objectives:
  • Evolving challenges in small molecule API synthesis
  • Principles of retrosynthetic analysis and its value in drugmaking
  • How advanced retrosynthetic analysis tools enable more sophisticated and efficient drug development

Brought to you by:
Lonza Small Molecules
Please complete the form to download the white paper.
*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

Copyright © 2023 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy